Modulating protein-protein interactions with small molecules: The importance of binding hotspots

40Citations
Citations of this article
120Readers
Mendeley users who have this article in their library.

Abstract

The modulation of protein-protein interactions (PPIs) by small drug-like molecules is a relatively new area of research and has opened up new opportunities in drug discovery. However, the progress made in this area is limited to a handful of known cases of small molecules that target specific diseases. With the increasing availability of protein structure complexes, it is highly important to devise strategies exploiting homologous structure space on a large scale for discovering putative PPIs that could be attractive drug targets. Here, we propose a scheme that allows performing large-scale screening of all protein complexes and finding putative small-molecule and/or peptide binding sites overlapping with protein-protein binding sites (so-called "multibinding sites"). We find more than 600 nonredundant proteins from 60 protein families with multibinding sites. Moreover, we show that the multibinding sites are mostly observed in transient complexes, largely overlap with the binding hotspots and are more evolutionarily conserved than other interface sites. We investigate possible mechanisms of how small molecules may modulate protein-protein binding and discuss examples of new candidates for drug design.

Cite

CITATION STYLE

APA

Thangudu, R. R., Bryant, S. H., Panchenko, A. R., & Madej, T. (2012). Modulating protein-protein interactions with small molecules: The importance of binding hotspots. Journal of Molecular Biology, 415(2), 443–453. https://doi.org/10.1016/j.jmb.2011.12.026

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free